The Vivaldi 2 study will more than triple in size to provide a detailed picture of coronavirus infection in care homes in England.
Beckman Coulter has announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark.
Responding to the Prime Minister’s statement on coronavirus, NHS Medical Director, Professor Stephen Powis, said: “Daily hospital COVID admissions are now higher than on 23 March when the Prime Minister announced the first national lockdown.
Imperial’s COVID-19 vaccine lead, Professor Robin Shattock, has told MPs that there is uncertainty around the immunity that a vaccine will offer; boosting strategies may be required and we are likely to be living with the virus for years to come.
Two antiviral drugs are being given to COVID-19 positive adults to establish if they stop the virus replicating, as part of a trial led by UCL scientists.
NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) have given more details about the forthcoming guideline on post-COVID syndrome which is due to be published by the end of the year.
A new study suggests myocarditis caused by COVID-19 may be a relatively rare occurrence.
Biologics increase COVID-19 infection risk but may protect psoriatic patients from ICU hospitalisation and death.
A government-led project is successfully detecting traces of coronavirus in sewage, providing an early warning for local outbreaks across the country and sharing data with NHS Test and Trace.
Hundreds of patients who turn up to A&E departments in Birmingham may be turned away in a bid to protect key services, health bosses have said.
NICE and the Scottish Intercollegiate Guidelines Network (SIGN) have announced they will work with the Royal College of General Practitioners (RCGP) to develop a guideline on persistent effects of COVID-19 (Long Covid) on patients.
People suffering ‘long COVID’ symptoms will be offered specialist help at clinics across England, the head of the NHS has announced.
The UK Government has entered into a contract with Abingdon Health, on behalf of the UK-Rapid Test Consortium (“UK-RTC”), for the supply of the AbC-19 Rapid Antibody tests.
Interim results from the fourth report of the country’s largest study on coronavirus rates of infection have been published.
A committee of MPs has highlighted the impact and unprecedented challenge caused by COVID-19 to the provision of essential services.
More than 10 percent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself, new research shows. Another 3.5 percent, at least, carry a specific genetic mutation.